TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16556618

Group type: EXPERIMENTAL
Intervention: Antioxidant supplements (beta carotene and vitamins C and E)
Number of subjects: 798

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 798
Study: 12926746

Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and application of tap water flavoured with eucalyptus oil
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and application of Cervitec (1% chlorhexidine in thymol-containing varnish)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Professional tooth cleaning and application of Cervitec and Fluor Protector (varnish containing 0.1% fluoride)
Number of subjects: 15

Group type: COMPARATOR
Intervention: All treatment groups combined
Number of subjects: 15
Study: 11007223

Group type: EXPERIMENTAL
Intervention: Erythromycin (200 mg intravenously over 20 min, followed by 100 mg over the next 40 min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 8
Study: 8788536

Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg, equivalent to 2-3 cups of coffee)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no caffeine)
Number of subjects: 48
Study: 1632541

Group type: EXPERIMENTAL
Intervention: Continuous low-dose infusion of 0.125% bupivacaine at 6 mL/h after a 3-in-1 nerve block with 30 mL of 0.25% bupivacaine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (conventional intramuscularly administered narcotics)
Number of subjects: 37
Study: 6437476

Group type: EXPERIMENTAL
Intervention: Two stage ultrasound screening schedule
Number of subjects: 877

Group type: COMPARATOR
Intervention: Routine application of two stage ultrasound screening
Number of subjects: 877
Study: 31585008

Group type: EXPERIMENTAL
Intervention: Lower resting-state complexity within sensorimotor, executive and attention networks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Complexity in sensorimotor, executive and attention networks
Number of subjects: 53
Study: 28088776

Group type: EXPERIMENTAL
Intervention: ACR
Number of subjects: 5552

Group type: EXPERIMENTAL
Intervention: eAER
Number of subjects: 5552
Study: 27536093

Group type: EXPERIMENTAL
Intervention: Audiovisual educational interventions (three groups)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Pamphlet (control group)
Number of subjects: 91
Study: 24872540

Group type: EXPERIMENTAL
Intervention: Lung cancer screening with major abnormality not suspicious for lung cancer
Number of subjects: 15489

Group type: EXPERIMENTAL
Intervention: Lung cancer screening with suspicious for lung cancer but stable from previous screens
Number of subjects: 15489

Group type: EXPERIMENTAL
Intervention: Lung cancer screening with suspicious for lung cancer and new or changed from previous screen
Number of subjects: 15489

Group type: COMPARATOR
Intervention: Normal lung cancer screening results
Number of subjects: 15489
Study: 22974129

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (IT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (MT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All interventions (IT, MT, OMT)
Number of subjects: 60
Study: 25427182

Group type: EXPERIMENTAL
Intervention: Scaling and root planing with adjunctive laser therapy (5W), n=28
Number of subjects: 8

Group type: COMPARATOR
Intervention: Scaling and root planing (control), n=28
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Laser surgery (7W) for remaining pockets
Number of subjects: 8

Group type: COMPARATOR
Intervention: Gingivectomy (control) for remaining pockets
Number of subjects: 8
Study: 18534500

Group type: EXPERIMENTAL
Intervention: Posterior cruciate-retaining (CR) total knee arthroplasties (TKAs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Posterior cruciate-substituting (PS) total knee arthroplasties (TKAs)
Number of subjects: 60
Study: 16036208

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (0.7 g/kg for males and 0.6 g/kg for females)
Number of subjects: 32
Study: 11829698

Group type: EXPERIMENTAL
Intervention: Dietary treatment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/d)
Number of subjects: 120
Study: 10640168

Group type: EXPERIMENTAL
Intervention: MPA/E2C
Number of subjects: 1103

Group type: COMPARATOR
Intervention: NET/EE (new users)
Number of subjects: 1103

Group type: COMPARATOR
Intervention: NET/EE (previous users)
Number of subjects: 1103
Study: 7791577

Group type: EXPERIMENTAL
Intervention: Experimental group (E) exercised for 30 min, 3 d.wk‐1 for 12 wk at 70% (initial 6 wk) and 80% (latter 6 wk) of maximum heart rate.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (C) maintained normal activity pattern.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Experimental group (E) post conditioning RFC.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups pre and post conditioning after maximal exercise.
Number of subjects: 25
Study: 2044644

Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 3908

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3908
Study: 7174412

Group type: EXPERIMENTAL
Intervention: VE (ventilatory index)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: VCO2 (ventilatory index)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: R (ventilatory index)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: VE/VO2 (ventilatory index)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HLa (blood lactate concentration)
Number of subjects: 16
Study: 31449735

Group type: EXPERIMENTAL
Intervention: Septo-RFA (septoplasty with radiofrequency ablation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Septo-Sham (septoplasty with sham surgery)
Number of subjects: 60
Study: 30099096

Group type: EXPERIMENTAL
Intervention: Daily nitrate supplementation (70 mL beetroot juice, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (70 mL nitrate-depleted beetroot juice, n = 20)
Number of subjects: 40
Study: 27638636

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 77
Study: 25455119

Group type: EXPERIMENTAL
Intervention: Community health worker-led diabetes education and management intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 180
Study: 22119338

Group type: EXPERIMENTAL
Intervention: Lowest-resistance TENS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random TENS
Number of subjects: 0
Study: 20010118

Group type: EXPERIMENTAL
Intervention: Caloric restriction plus aerobic exercise (CR + EX)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 36
Study: 16631281

Group type: EXPERIMENTAL
Intervention: Reminiscence education program (2-hour session) followed by a 13-week implementation during community health practicum
Number of subjects: 64

Group type: COMPARATOR
Intervention: None (no-treatment control group)
Number of subjects: 64
Study: 16175011

Group type: EXPERIMENTAL
Intervention: Stenting plus abciximab
Number of subjects: 293

Group type: COMPARATOR
Intervention: Thrombolysis (alteplase alone or alteplase plus abciximab)
Number of subjects: 293
Study: 12420857

Group type: EXPERIMENTAL
Intervention: Azithromycin 4.5 g total for 3 weeks (1 x 500 mg weekly for 3 days)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg b.i.d. for 15 days
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Azithromycin for asymptomatic chlamydial prostatitis
Number of subjects: 123

Group type: COMPARATOR
Intervention: Clarithromycin for asymptomatic chlamydial prostatitis
Number of subjects: 123
Study: 9849710

Group type: EXPERIMENTAL
Intervention: Mifepristone-misoprostol abortion
Number of subjects: 1373

Group type: COMPARATOR
Intervention: Surgical abortion
Number of subjects: 1373
Study: 8546288

Group type: EXPERIMENTAL
Intervention: New lightweight device for detection of tracheal tube placement
Number of subjects: 0
Study: 1978480

Group type: EXPERIMENTAL
Intervention: Remoxipride 50 mg single dose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Remoxipride 50 mg, 100 mg, and 200 mg twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (young adults 19-36 years)
Number of subjects: 10
Study: 349155

Group type: EXPERIMENTAL
Intervention: Rubidium chloride; dosage not specified; duration not specified
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31872219

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 881

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Third trimester 25(OH)D levels
Number of subjects: 881
Study: 31262489

Group type: EXPERIMENTAL
Intervention: Lower uromodulin (hazard ratio per two-fold higher)
Number of subjects: 2351

Group type: EXPERIMENTAL
Intervention: Higher α1m (hazard ratio)
Number of subjects: 2351

Group type: EXPERIMENTAL
Intervention: Longitudinal increases in urine NGAL, IL-19, and YKL-40
Number of subjects: 2351

Group type: EXPERIMENTAL
Intervention: Longitudinal increase in α1m
Number of subjects: 2351

Group type: EXPERIMENTAL
Intervention: None of the five injury markers
Number of subjects: 2351
Study: 28404154

Group type: COMPARATOR
Intervention: Interval appendicectomy
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Active observation
Number of subjects: 106
Study: 25807814

Group type: EXPERIMENTAL
Intervention: Syndrome Differentiated Chinese Medicine Therapy
Number of subjects: 396

Group type: COMPARATOR
Intervention: Losartan 50 mg/d
Number of subjects: 396
Study: 21834863

Group type: EXPERIMENTAL
Intervention: Lingual gold onlay
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resilient mouth guard
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Screw-retained implant-supported full-arch casted titanium-resin prostheses
Number of subjects: 24
Study: 20719873

Group type: EXPERIMENTAL
Intervention: Print-focused reading sessions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Picture-focused condition
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sound-focused condition
Number of subjects: 62
Study: 19017277

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 50
Study: 16960172

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 81
Study: 15554354

Group type: EXPERIMENTAL
Intervention: Pregnant women before delivery
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy nonpregnant women
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Pregnant women after delivery
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (nonpregnant women)
Number of subjects: 19
Study: 11318251

Group type: EXPERIMENTAL
Intervention: Worry about STD
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Worry about HIV
Number of subjects: 522
Study: 10759235

Group type: EXPERIMENTAL
Intervention: IFN‐alpha2b, 5 MU daily plus ribavirin
Number of subjects: 10

Group type: COMPARATOR
Intervention: IFN‐alpha2b, 5 MU three times a week plus ribavirin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 10
Study: 8797030

Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction (PCR) method
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Serological methods (complement fixation test and enzyme‐immunoassay)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: PCR method
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Concomitant assays of PCR and Ab
Number of subjects: 22
Study: 1569815

Group type: EXPERIMENTAL
Intervention: 13‐RED regimen (twice weekly rifampicin 600 mg, daily ethionamide 500 mg, dapsone 100 mg)
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Reduced dosage of ethionamide to 5 mg/k bodyweight in the RED group
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: REC regimen (clofazimine 100 mg)
Number of subjects: 559
Study: 6339294

Group type: EXPERIMENTAL
Intervention: halometasone/triclosan cream
Number of subjects: 220

Group type: COMPARATOR
Intervention: fluocinolone acetonide/neomycin cream
Number of subjects: 220

Group type: COMPARATOR
Intervention: fluprednylidene acetate/gentamicin/chlorohydroxyquinoline cream
Number of subjects: 220
Study: 31009243

Group type: EXPERIMENTAL
Intervention: Balance training with VR (Nintendo Wii Fit system™) for 1 week, 3 sessions
Number of subjects: 29

Group type: COMPARATOR
Intervention: No intervention (Control Group)
Number of subjects: 29
Study: 28069835

Group type: EXPERIMENTAL
Intervention: High-density multielectrode mapping (MEM)
Number of subjects: 20
Study: 25217316

Group type: EXPERIMENTAL
Intervention: Closed-wedge osteotomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open-wedge osteotomy
Number of subjects: 50
Study: 25223482

Group type: EXPERIMENTAL
Intervention: Epirubicin/cyclophosphamide followed by docetaxel with bevacizumab (8 infusions every 3 weeks)
Number of subjects: 1948

Group type: COMPARATOR
Intervention: Epirubicin/cyclophosphamide followed by docetaxel without bevacizumab
Number of subjects: 1948

Group type: EXPERIMENTAL
Intervention: Paclitaxel with everolimus (5 mg/day)
Number of subjects: 1948

Group type: COMPARATOR
Intervention: Paclitaxel without everolimus
Number of subjects: 1948
Study: 21707775

Group type: EXPERIMENTAL
Intervention: Cold air analgesia
Number of subjects: 43

Group type: COMPARATOR
Intervention: No cold air analgesia (control)
Number of subjects: 43
Study: 19682909

Group type: EXPERIMENTAL
Intervention: Water-filled soft brace
Number of subjects: 73

Group type: COMPARATOR
Intervention: Hard brace
Number of subjects: 73
Study: 17012341

Group type: EXPERIMENTAL
Intervention: Active deep brain stimulation (DBS)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 5
Study: 15774257

Group type: EXPERIMENTAL
Intervention: 500 mg levofloxacin
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 320/1600 mg trimethoprim/sulfamethoxazole (TMP/SMZ)
Number of subjects: 400

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 400
Study: 11777506

Group type: EXPERIMENTAL
Intervention: Immediate pushing at complete dilatation
Number of subjects: 252

Group type: COMPARATOR
Intervention: Rest period before pushing
Number of subjects: 252
Study: 9660087

Group type: EXPERIMENTAL
Intervention: hCG/human menopausal gonadotropin treatment in IHH patients
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Testosterone treatment in Klinefelter's syndrome patients
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (normal men)
Number of subjects: 37
Study: 7706066

Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison group (no therapeutic touch)
Number of subjects: 40
Study: 2515720

Group type: EXPERIMENTAL
Intervention: Selegiline 10 mg per day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 31392518

Group type: EXPERIMENTAL
Intervention: Peripheral access
Number of subjects: 150

Group type: COMPARATOR
Intervention: Central access
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall complications
Number of subjects: 150
Study: 28710052

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Nutritional Intervention (MDNI) for 12 months
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Usual care for 12 months
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Nutritional Intervention (MDNI) for 6 months (after crossover)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Self-sustained continuation phase for 6 months (after crossover)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Changes in body weight, body composition, and other cardiometabolic risk markers
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Self-reported dietary habits and biomarkers of dietary adherence
Number of subjects: 1000
Study: 25110844

Group type: EXPERIMENTAL
Intervention: PA plus RTR intervention delivered by RTR volunteers
Number of subjects: 76

Group type: COMPARATOR
Intervention: Contact control (RTR control)
Number of subjects: 76
Study: 24228901

Group type: EXPERIMENTAL
Intervention: Lifestyle changes (modified Mediterranean diet and moderate physical exercise for 20 weeks)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Lifestyle changes
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Red wine (100 ml for women, 200 ml for men daily)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Any intervention
Number of subjects: 108
Study: 21450674

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 or 40 mg
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Participants reaching 2.0 mmol/l LDL-C
Number of subjects: 1000
Study: 19335418

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment (once-daily application)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment (twice-daily application)
Number of subjects: 53
Study: 16455435

Group type: EXPERIMENTAL
Intervention: Tai Chi intervention
Number of subjects: 0
Study: 15236620

Group type: EXPERIMENTAL
Intervention: Amprenavir (APV) boosted with low-dose ritonavir (RTV, 100 mg bid)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Standard of care (SOC) protease inhibitors (PIs) with or without low-dose RTV
Number of subjects: 163
Study: 11215552

Group type: EXPERIMENTAL
Intervention: Family economic support
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Caregiving hours
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Informal support
Number of subjects: 203
Study: 9328113

Group type: EXPERIMENTAL
Intervention: CD28 costimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD28 costimulation in lymphocyte cultures with HIV-1 gp160 or p24
Number of subjects: 0

Group type: COMPARATOR
Intervention: CD3-mediated responses
Number of subjects: 0
Study: 8252662

Group type: EXPERIMENTAL
Intervention: Parnaparin
Number of subjects: 29
Study: 3302764

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 91

Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 91
Study: 30314506

Group type: EXPERIMENTAL
Intervention: Conservative TMD treatment with a maximum of 18 sessions within 9 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed-start group (no treatment for 9 weeks)
Number of subjects: 0
Study: 29126228

Group type: EXPERIMENTAL
Intervention: High-Frequency Spinal Cord Stimulation (HF SCS)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional Frequency Spinal Cord Stimulation (CF SCS)
Number of subjects: 78
Study: 26261987

Group type: COMPARATOR
Intervention: Psychological first aid and psychoeducation at discharge from hospital (Group B)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Psychological first aid and psychoeducation at discharge and a second intervention one month later based on cognitive behavioural principles (Group C)
Number of subjects: 225

Group type: COMPARATOR
Intervention: No intervention (Group A)
Number of subjects: 225
Study: 24075505

Group type: EXPERIMENTAL
Intervention: Hypocaloric high fat low carbohydrate diet (HFLC) for 12 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Low fat high carbohydrate diet (LFHC) for 12 weeks
Number of subjects: 55
Study: 21377273

Group type: EXPERIMENTAL
Intervention: ABT-102 4 mg twice a day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 18755719

Group type: EXPERIMENTAL
Intervention: GEWF solution preparation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional preparation
Number of subjects: 120
Study: 17205815

Group type: EXPERIMENTAL
Intervention: Modified Wuzi Yanzong Granule (WYG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 36
Study: 14693069

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy based on chemosensitivity testing in nude mouse assay (Group I)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard regimen adjuvant chemotherapy (Group C) - cyclophosphamide (CTX) 600 mg/m² d1 + Adriamycin (ADM) 40 mg/m² d1 + cisplatin (DDP) 20 mg/m² d1-5
Number of subjects: 130
Study: 10751105

Group type: EXPERIMENTAL
Intervention: Simulated altitude of 2650 m for 5 nights (8-11 hours per night)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group at near-sea-level conditions (600 m altitude)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Subsequent hypoxic exposures after 3 nights at near sea level
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 6
Study: 8642852

Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA: 8 mg/m2/day, i.v. bolus for 5 days)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Daunorubicin (DNR: 50 mg/m2/day, i.v. bolus for 3 days)
Number of subjects: 220
Study: 1515246

Group type: EXPERIMENTAL
Intervention: Conservation technique
Number of subjects: 197

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 197
Study: 6230249

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 200 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 80 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 27768615

Group type: COMPARATOR
Intervention: etafilcon A (ACUVUE 2, control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: lotrafilcon B (Air Optix Aqua)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: comfilcon A (Biofinity)
Number of subjects: 36

Group type: COMPARATOR
Intervention: etafilcon A vs lotrafilcon B
Number of subjects: 36

Group type: COMPARATOR
Intervention: etafilcon A vs comfilcon A
Number of subjects: 36

Group type: COMPARATOR
Intervention: etafilcon A
Number of subjects: 36
Study: 26641557

Group type: EXPERIMENTAL
Intervention: OSNAP Initiative (intervention group)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 402
Study: 24233069

Group type: EXPERIMENTAL
Intervention: 22-gauge needle
Number of subjects: 93

Group type: COMPARATOR
Intervention: 25-gauge needle
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both needles
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Post-LP headache
Number of subjects: 93
Study: 23517382

Group type: EXPERIMENTAL
Intervention: Autologous noncultured epidermal cell suspension (NCES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Autologous noncultured extracted hair follicle outer root sheath cell suspension (NCORSHFS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both NCES and NCORSHFS
Number of subjects: 30